Lactobacilli-containing vaginal probiotics to cure or prevent bacterial or fungal vaginal dysbiosis: a systematic review and recommendations for future trial designs.

CONCLUSIONS: Availability of vaginal probiotics for vaginal health indications will likely decline in 2020 because of regulatory changes. We urge the field to invest in clinical evidence-based product development, and to conduct future trials more rigorously. This article is protected by copyright. All rights reserved.
PMID: 31299136 [PubMed - as supplied by publisher]

Source: BJOG : An International Journal of Obstetrics and Gynaecology - July 11, 2019 Category: OBGYN Authors: van de Wijgert JHHM, Verwijs MC Tags: BJOG Source Type: research